phosphoserine has been researched along with Triple Negative Breast Neoplasms in 3 studies
Phosphoserine: The phosphoric acid ester of serine.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Angiogenesis facilitates TNBC metastases." | 1.62 | Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases. ( Al Bayati, A; Blonska, M; Carroll, SF; Cho, HM; Das, R; Elledge, C; Gil-Henn, H; Pimentel, A; Ramakrishnan, S; Rosenblatt, JD; Sankar, AP; Shin, SU; Zhang, Y, 2021) |
| "Metastasis is the major cause of TNBC mortality." | 1.62 | Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases. ( Al Bayati, A; Blonska, M; Carroll, SF; Cho, HM; Das, R; Elledge, C; Gil-Henn, H; Pimentel, A; Ramakrishnan, S; Rosenblatt, JD; Sankar, AP; Shin, SU; Zhang, Y, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Shin, SU | 1 |
| Cho, HM | 1 |
| Das, R | 1 |
| Gil-Henn, H | 1 |
| Ramakrishnan, S | 1 |
| Al Bayati, A | 1 |
| Carroll, SF | 1 |
| Zhang, Y | 1 |
| Sankar, AP | 1 |
| Elledge, C | 1 |
| Pimentel, A | 1 |
| Blonska, M | 1 |
| Rosenblatt, JD | 1 |
| De, S | 1 |
| Tsimounis, A | 1 |
| Chen, X | 1 |
| Rotenberg, SA | 1 |
| Shu, S | 1 |
| Lin, CY | 1 |
| He, HH | 1 |
| Witwicki, RM | 1 |
| Tabassum, DP | 1 |
| Roberts, JM | 1 |
| Janiszewska, M | 1 |
| Huh, SJ | 1 |
| Liang, Y | 1 |
| Ryan, J | 1 |
| Doherty, E | 1 |
| Mohammed, H | 1 |
| Guo, H | 1 |
| Stover, DG | 1 |
| Ekram, MB | 1 |
| Brown, J | 1 |
| D'Santos, C | 1 |
| Krop, IE | 1 |
| Dillon, D | 1 |
| McKeown, M | 1 |
| Ott, C | 1 |
| Qi, J | 1 |
| Ni, M | 1 |
| Rao, PK | 1 |
| Duarte, M | 1 |
| Wu, SY | 1 |
| Chiang, CM | 1 |
| Anders, L | 1 |
| Young, RA | 1 |
| Winer, E | 1 |
| Letai, A | 1 |
| Barry, WT | 1 |
| Carroll, JS | 1 |
| Long, H | 1 |
| Brown, M | 1 |
| Liu, XS | 1 |
| Meyer, CA | 1 |
| Bradner, JE | 1 |
| Polyak, K | 1 |
3 other studies available for phosphoserine and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.
Topics: Angiogenesis Inhibitors; Animals; Antibody-Dependent Cell Cytotoxicity; Cell Line, Tumor; Cell Proli | 2021 |
Phosphorylation of α-tubulin by protein kinase C stimulates microtubule dynamics in human breast cells.
Topics: 4-Butyrolactone; Breast; Cell Line, Transformed; Cell Movement; Cell Survival; Enzyme Activation; Fe | 2014 |
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.
Topics: Animals; Azepines; Binding, Competitive; Casein Kinase II; Cell Cycle Proteins; Cell Line, Tumor; Ce | 2016 |